Tcr2 Therapeutics Inc.

CITIGROUP INC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/11/2023

Shares

383,486

Value ($000)

575

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/11/2023	575	0.0%	383,486	3/31/2023
2022 Q4	2/9/2023	473	0.0%	473,484	12/31/2022
2022 Q3	11/10/2022	1	0.0%	459	9/30/2022
2022 Q2	8/10/2022	3	0.0%	1,035	6/30/2022
2022 Q1	5/12/2022	6	0.0%	2,142	3/31/2022
2021 Q4	2/10/2022	41	0.0%	8,876	12/31/2021
2021 Q3	11/10/2021	426	0.0%	50,023	9/30/2021
2021 Q2	8/10/2021	2,644	0.0%	161,146	6/30/2021
2021 Q1	5/13/2021	3,392	0.0%	153,642	3/31/2021
2020 Q4	2/11/2021	369	0.0%	11,942	12/31/2020
2020 Q3	11/12/2020	37	0.0%	1,808	9/30/2020
2020 Q2	8/12/2020	47	0.0%	3,028	6/30/2020
2020 Q1	5/12/2020	47	0.0%	6,060	3/31/2020
2019 Q4	2/12/2020	44	0.0%	3,049	12/31/2019